 The Oncology Report | Fake and Gray Market Drugs Vex US Oncologists The Oncology Report The agency named Faslodex (fulvestrant), Neupogen (filgrastim), Rituxan (rituximab) and Herceptin (trastuzumab) – but not Avastin – in the warning. Subsequently, the United States Attorney's Office for the Eastern District of Missouri announced that a ... |
